X
Xeris Biopharma Holdings, Inc. (XERS)
NMS – Real Time Price. Currency in USD
6.26
+0.12 (1.95%)
At close: May 12, 2026, 4:00 PM EDT
6.23
-0.03 (-0.48%)
After-hours: May 12, 2026, 7:25 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
6.26
+0.12 (1.95%)
At close: May 12, 2026, 4:00 PM EDT
6.23
-0.03 (-0.48%)
After-hours: May 12, 2026, 7:25 PM EDT
No Data
There are no news for this stock.
Total debt $258.6M significantly exceeds cash reserves ($111.8M), raising financial stability concerns
Total current assets $251.7M exceed Total current liabilities $118.6M, highlighting excellent liquidity
Debt-to-equity ratio (19.9) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (1.1x) is dangerously low, suggesting debt repayment risks
The company generates positive free cash flow $9.5M, supporting its financial health
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.12 | 6.05 | 10 | |
| Quick ratio | 1.50 | 5.63 | 7.0 | |
| Debt to Equity | 19.87 | 0.30 | 2.0 | |
| Debt to Assets | 0.66 | 1.04 | 3.0 | |
| Interest coverage | 1.15 | -16.91 | 4.0 | |
| Weighted average score | 5.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 110M | 164M | 203M | 292M | 315M |
| Gross Profit | 77M | 124M | 155M | 238M | 260M |
| Operating Income | -80M | -44M | -34M | 25M | 36M |
| Net Income | -95M | -62M | -55M | 554K | 12M |
| EBITDA | -68M | -31M | -21M | 38M | 48M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 27.19 | 285.71 | 10 |
| Next quarter | 35.61 | N/A | 5.5 |
| Current year | 31.8 | 3998.19 | 10 |
| Next year | 22.16 | 157.61 | 10 |
| Weighted average score | 8.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -3.11 | -79.83 | -83.32 | -51.56 | 1.0 |
| Y/Y | 38.27 | 124.23 | 116.67 | 195.03 | 10 |
| 3y average | 38.76 | 49.05 | 51.45 | 83.33 | 10 |
| 5y average | 76.26 | 27.08 | 47.35 | 44.72 | 10 |
| Weighted average score | 7.8 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |